Furthermore,through in vitro and in vivo experiments, we demonstrated that anti-tumor metabolites produced by F. rodentium can also modulate PDPN/CLEC-2/PI3K/AKT/mTOR signaling in CRC. The gene discussed is CLEC1B; the disease is colorectal carcinoma.